NEW YORK, Dec. 5 (GenomeWeb News) - Prolexys Pharmaceuticals, formerly Myriad Proteomics, announced today that it is collaborating with the Whitehead Institute to use compounds from Whitehead and Prolexys' HySpec mass spec platform and chemiproteomic techniques to find new oncology targets.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.